A phase II prospective study of sequential myeloablative chemotherapy with hematopoietic stem cell rescue for the treatment of selected high risk and recurrent central nervous system tumors

Journal of Neuro-Oncology

Volumn 97, Issue 2, 2010, Pages 247-255

  Rosenfeld, Amy ^a   Kletzel, Morris ^b   Duerst, Reggie ^b   Jacobsohn, David ^b   Haut, Paul ^c   Weinstein, Joanna ^b   Rademaker, Alfred ^d   Schaefer, Colleen ^b   Evans, Lauren ^b   Fouts, Molly ^b   Goldman, Stewart ^b  

^a PHOENIX CHILDREN'S HOSPITAL   (United States)

^b CHILDREN'S MEMORIAL HOSPITAL   (United States)

^c INDIANA UNIVERSITY SCHOOL OF MEDICINE   (United States)

^d NORTHWESTERN UNIVERSITY   (United States)

Author keywords

Chemotherapy; Hematopoietic stem cell rescue; Myeloablative; Pediatric high risk and brain tumors; Pediatric recurrent brain tumors

Indexed keywords

ACICLOVIR; CARBOPLATIN; CYCLOPHOSPHAMIDE; ETOPOSIDE; FLUCONAZOLE; GRANULOCYTE COLONY STIMULATING FACTOR; MELPHALAN; MESNA; PENTAMIDINE; THIOTEPA;

ADOLESCENT; ADULT; ANTIBIOTIC PROPHYLAXIS; ARTICLE; ASTROCYTOMA; BLOOD TOXICITY; BRAIN TUMOR; CANCER COMBINATION CHEMOTHERAPY; CENTRAL NERVOUS SYSTEM TUMOR; CHILD; CLINICAL ARTICLE; CLINICAL TRIAL; DRUG EFFICACY; DRUG SAFETY; DRUG TOLERABILITY; FEMALE; GERM CELL TUMOR; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HUMAN; MALE; MEDULLOBLASTOMA; MENINGIOMA; MUCOSA INFLAMMATION; MULTIPLE CYCLE TREATMENT; MYELODYSPLASTIC SYNDROME; OVERALL SURVIVAL; PHASE 2 CLINICAL TRIAL; PINEAL BODY TUMOR; THROMBOCYTE TRANSFUSION; TREATMENT RESPONSE; VEIN OCCLUSION;

ADOLESCENT; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; CARBOPLATIN; CENTRAL NERVOUS SYSTEM NEOPLASMS; CHILD; CHILD, PRESCHOOL; COMBINED MODALITY THERAPY; CYCLOPHOSPHAMIDE; ETOPOSIDE; FEMALE; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HUMANS; INFANT; KAPLAN-MEIERS ESTIMATE; MALE; MELPHALAN; THIOTEPA; TRANSPLANTATION CONDITIONING;

EID: 77950458480     PISSN: 0167594X     EISSN: 15737373     Source Type: Journal    
DOI: 10.1007/s11060-009-0009-z     Document Type: Article

References (18)

1. Mahoney DH, Strother D, Camitta B, Bowen T, Ghim T, Pick T, Wall D, Yu L, Shuster J, Friedman H (1996) High-dose mel-phalan and cyclophosphamide with autologous bone marrow rescue for recurrent/progressive malignant brain tumors in children: a pilot pediatric oncology group study. J Clin Oncol 14:382-388
2. Perez-Martinez A, Lassaletta A, Gonzalez-Vincent M, Sevilla J, Diaz A, Madero L (2005) High-dose chemotherapy with autol-ogous stem cell rescue for children with high risk and recurrent medulloblastoma and supratentorial primitive neuroectodermal tumors. J Neurooncol 71:33-38
3. Modak S, Gardner S, Dunkel I, Balmaceda C, Rosenblum M, Miller D, Halpern S, Finlay J (2004) Thiotepa-based high-dose chemotherapy with autologous stem-cell rescue in patients with recurrent or progressive CNS germ cell tumors. J Clin Oncol 22:1934-1943 (Pubitemid 41095186)
4. George R, Li S, Medeiros-Nacarrow C, Neuberg D, Marcus K, Shamberger R, Pulsipher M, Grupp S, Diller L (2006) High-risk neuroblastoma treated with tandem autologous peripheral-blood stem cell-supported transplantation: long-term survival update. J Clin Oncol 24:2891-2896
5. Kletzel M, Katzenstein H, Haut P, Yu A, Morgan E, Reynolds M, Geissler G, Marymount M, Liu D, Kalapurakal J, Shore R, Bardo D, Schmoldt J, Rademaker A, Cohn S (2002) Treatment of high-risk neuroblastoma with triple-tandem high-dose therapy and stem cell rescue: results of the Chicago Pilot II Study. J Clin Oncol 20:2284-2292
6. Jakacki R, Siffert J, Jamison C, Velasquez L, Allen J (1999) Dose-intensive, time compressed procarbazine, CCNU, vincris-tine (PCV) with peripheral blood stem cell support and concurrent radiation in patients with newly diagnosed high-grade gliomas. J Neurooncol 44:77-83
7. Jakacki R, Jamison C, Heifetz S, Caldemeyer K, Hanna M, Sender L (1997) Feasibility of sequential high-dose chemotherapy and peripheral blood stem cell support for pedi-atric central nervous system malignancies. Med Pediatr Oncol 29:553-559
8. Ozkaynak M, Sandoval C, Levendoglu-Tugal O, Jayabose S (2004) A pilot trial of tandem autologous peripheral blood progenitor cell transplantation following high-dose thiotepa and carboplatin in children with poor-risk central nervous system tumors. Pediatr Hematol Oncol 21:635-645
9. Finlay J, Goldman S, Wong M, Cairo M, Garvin J, August C, Cohen B, Stanley P, Zimmerman R, Bostrom B, Geyer R, Harris R, Sanders J, Yates A, Boyett J, Packer R (1996) Pilot study of high-dose thiotepa and etoposide with autologous bone marrow rescue in children and young adults with recurrent CNS tumors. J Clin Oncol 14:2495-2503
10. Cheuk D, Lee T, Chiang A, Ha S, Chan G (2008) Autologous hematopoietic stem cell transplantation for high-risk brain tumors in children. J Neurooncol 86:337-347
11. Dunkel I, Boyett J, Yates A, Rosenblum M, Garvin J, Bostrom B, Goldman S, Sender L, Gardner S, Li H, Allen J, Finlay J (1998) High-dose carboplatin, thiotepa, and etoposide with autologous stem-cell rescue for patients with recurrent medulloblastoma. J Clin Oncol 16:222-228
12. Graham M, Herndon J, Casey J, Chaffee S, Ciocci G, Krischer J, Kurtzberg J, Laughlin M, Longee D, Olson J, Paleologus N, Pennington C, Friedman H (1997) High-dose chemotherapy with autologous stem-cell rescue in patients with recurrent and high-risk pediatric brain tumors. J Clin Oncol 15:1814-1823
13. Lee ET (2000) Statistical methods for survival data analysis. Wiley, New York
14. Gooley T, Leisenring W, Crowley J, Storer B (1999) Estimation of failure probabilities in the presence of competing risks: new representations of old estimators. Stat Med 18:695-706
15. Gururangan S, Dunkel I, Goldman S, Garvin J, Rosenblum M, Boyett J, Gardner S, Merchant T, Gollamudi S, Finlay J (1998) Myeloablative chemotherapy with autologous bone marrow rescue in young children with recurrent malignant brain tumors. J Clin Oncol 16:2486-2493 (Pubitemid 28309045)
16. Papadakis V, Dunkel I, Cramer L, Kramer E, Papadopoulos E, Goldman S, Packer R, Willoughby M, Baker D, Garvin J, Strandjord S, Coccia P, Kaplan A, Klemperer M, Finlay J (2000) High-dose carmustine, thiotepa and etoposide followed by autologous bone marrow rescue for the treatment of high risk central nervous system tumors. Bone Marrow Transplant 26: 153-160
17. Papadopoulos K, Garvin J, Fetell M, Vahdat L, Garrett T, Savage D, Balmaceda C, Bruce J, Sisti M, Isaacson S, De LaPaz R, Hawks R, Bagiella E, Antman K, Hesdorffer C (1998) High-dose thiotepa and etoposide-based regimens with autologous hemato-poietic support for high-risk or recurrent CNS tumors in children and adults. Bone Marrow Transplant 22:661-667
18. Jonge M, Huitema A, Beijnen J, Rodenhuis S (2006) High exposures to bioactivated cyclophosphamide are related to the occurrence of veno-occlusive disease of the liver following high-dose chemotherapy. Br J Cancer 94:1226-1230